LABORATORY RESEARCH Leptin Mediates Tumor-Stromal Interactions that Promote the Invasive Growth of Breast Cancer Cells In this study, researchers identify a role for the obesity cytokine leptin, which has been implicated previously in breast cancer development, as a determinant for the tumor-promoting activity of cancer-associated fibroblasts in both wild-type and K303R mutant ERα-expressing breast cancer cells. [Cancer Res] Abstract The PKCθ Pathway Participates in the Aberrant Accumulation of Fra-1 Protein in Invasive ER-Negative Breast Cancer Cells Here, researchers show that the concentration of Fra-1 is high in invasive estrogen receptor (ER)-negative breast cancer cell lines, regardless of their Ras pathway status. [Oncogene] Abstract The ShcA SH2 Domain Engages a 14-3-3/Phosphatidylinositol 3 Kinase Signaling Complex and Promotes Breast Cancer Cell Survival Using transplantation approaches, researchers demonstrate that Src homology 2 domain (SH2)-dependent ShcA signaling within the mammary epithelial compartment is essential for breast tumor outgrowth, survival and the development of lung metastases. [Oncogene] Abstract Estrogenic Regulation of S6K1 Expression Creates a Positive Regulatory Loop in Control of Breast Cancer Cell Proliferation In this report, researchers demonstrate that estrogen activates expression of S6 kinase 1 (S6K1) via estrogen receptor (ER)α in ER-positive breast cancer cells. [Oncogene] Abstract Phospho-Ibuprofen (MDC-917) Suppresses Breast Cancer Growth: An Effect Controlled by the Thioredoxin System Researchers have recently synthesized MDC-917, a safer derivative of ibuprofen, which has shown anticancer activity. Here, researchers investigated its efficacy and mechanism of action in the treatment of breast cancer in preclinical models. [Breast Cancer Res] Abstract Inactivation of GPR30 Reduces Growth of Triple-Negative Breast Cancer Cells: Possible Application in Targeted Therapy Triple-negative breast tumors frequently express membrane bound estrogen receptor G-protein coupled receptor (GPR30). As proof of principle, researchers analyzed the consequences of a knock-down of GPR30 expression on the growth regulation of triple-negative breast cancer cell lines. [Breast Cancer Res Treat] Abstract Adenovirus-Mediated Aurora A Short Hairpin RNA Driven by Stathmin Promoter Suppressed Tumor Growth and Enhanced Paclitaxel Chemotherapy Sensitivity in Human Breast Carcinoma Cells In this study, researchers developed a novel tumor-specific RNA interference adenovirus system targeting Aurora A by using stathmin promoter and investigated the effects of it on the proliferation, apoptosis and chemotherapy sensitivity in human breast carcinoma cells both in vitro and in vivo. [Cancer Gene Ther] Abstract Loss of miR-133a Expression Associated with Poor Survival of Breast Cancer and Restoration of miR-133a Expression Inhibited Breast Cancer Cell Growth and Invasion Cell viability, migration, and invasion assays were used to determine the role of miR-133a in regulation of breast cancer cell growth, migration, and invasion, respectively. [BMC Cancer] Abstract CLINICAL RESEARCH IGFBP Ratio Confers Resistance to IGF Targeting and Correlates with Increased Invasion and Poor Outcome in Breast Tumors The purpose of this study was to improve the significance of insulin-like growth factor binding protein 5 (IGFBP-5) as a prognostic and potentially predictive marker in breast cancer patients. [Clin Cancer Res] Abstract An Open-Label, Phase II Trial of RPI.4610 (Angiozyme) in the Treatment of Metastatic Breast Cancer This phase II, multicenter, single-arm study was designed to assess the objective response rate of RPI.4610 in patients with metastatic breast cancer (MBC) who had experienced disease progression with at least one course of chemotherapy for MBC. [Cancer] Abstract Clinical Significance of CD151 Overexpression in Subtypes of Invasive Breast Cancer In this study, CD151 overexpression was found to be significantly associated with larger tumor size, higher nodal stage, advanced stage, absence of oestrogen receptor and progesterone receptor, and human epidermal growth factor receptor 2 overexpression. [Br J Cancer] Abstract |